Author:
Li Li,Wang Dianhua,Zhang Xuan,Song Xing
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet, 2011, 378: 1949–1961.
2. Lee SH, Shim HS, Cho SH, et al. Prognostic factors for idiopathic pulmonary fibrosis: clinical, physiologic, pathologic, and molecular aspects. Sarcoidosis Vasc Diffuse Lung Dis, 2011, 28: 102–112.
3. Wang WW, Ou’yang XN, Chen X, et al. Initial outcome of induction chemotherapy followed by radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer. Chinese-German J Clin Oncol, 2013, 12: 310–314.
4. Gifford AH, Matsuoka M, Ghoda LY, et al. Chronic inflammation and lung fibrosis: pleotropic syndromes but limited distinct phenotypes. Mucosal Immunol, 2012, 5: 480–484.
5. McCarthy C, Dimitrov BD, Meurling IJ, et al. The CF-ABLE score: a novel clinical prediction rule for prognosis in patients with cystic fibrosis. Chest, 2013, 143: 1358–1364.